Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-08-000159
Filing Date
2008-02-14
Accepted
2008-02-14 16:15:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2008 synta13ga-021408.htm SC 13G/A 161530
  Complete submission text file 0001013594-08-000159.txt   163255
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-82674 | Film No.: 08615922
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10153 212-763-8000
Luxor Capital Group, LP (Filed by) CIK: 0001316580 (see all company filings)

EIN.: 201394199 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A